What is the best medication to promote bowel movements in an adult with paraplegia and neurogenic bowel dysfunction?

Best Medication for Bowel Movement in Paraplegic Patients

Start with polyethylene glycol (PEG/macrogol) 17g twice daily combined with a stimulant laxative like senna or bisacodyl 10-15mg daily, titrating to achieve one non-forced bowel movement every 1-2 days. This combination addresses both stool consistency and colonic motility, which are the primary mechanisms disrupted in neurogenic bowel dysfunction from paraplegia 1.

Initial Pharmacological Approach

For paraplegic patients with neurogenic bowel dysfunction, the medication strategy should follow this algorithmic sequence:

First-Line: Osmotic + Stimulant Laxative Combination

• Osmotic laxative (PEG/macrogol): 17g with 8 oz water twice daily 1

  • PEG sequesters fluid in the bowel, softening stool without the electrolyte disturbances of magnesium or sodium salts
  • Superior to lactulose for most patients as it doesn't cause gas/bloating

• Stimulant laxative: Add senna 2-3 tablets twice daily OR bisacodyl 10-15mg daily 1, 2

  • Stimulates myenteric plexus in the colon to increase motility
  • Essential because paraplegics have impaired colonic propulsion

Important caveat: Avoid docusate sodium as a stool softener—multiple studies show it provides no additional benefit when combined with stimulant laxatives 3, 2. This is a common prescribing error.

Second-Line: Enhanced Stimulation

If inadequate response after 1-2 weeks:

• Increase bisacodyl to 10-15mg three times daily 2
• Add magnesium-based laxatives (magnesium hydroxide 30-60mL daily or magnesium citrate 8oz daily) for rapid evacuation 1
• Consider rectal bisacodyl suppositories (10mg) once or twice daily 1, 2
  • Polyethylene glycol-based (PGB) bisacodyl suppositories are superior to hydrogenated vegetable oil-based versions, reducing defecation time from 36 to 20 minutes 4

Third-Line: Prokinetic Agents

For refractory constipation despite maximal laxative therapy:

• Prucalopride (5-HT4 receptor agonist): Selective serotonin agonist with prokinetic properties 1

  • Does NOT prolong QT interval (unlike withdrawn agents cisapride and tegaserod)
  • Licensed for chronic constipation when other laxatives fail
  • Most common side effects: headache, abdominal pain, nausea (usually transient)

• Pyridostigmine (parasympathomimetic): Enhances parasympathetic activity 1

  • Shown effective for refractory constipation using stepped dosing
  • Monitor for cardiovascular side effects (bradycardia)

Critical Clinical Considerations

What to Avoid

• Bulk-forming laxatives (psyllium, methylcellulose): Ineffective and may worsen constipation in neurogenic bowel unless patient has adequate fluid intake and some preserved motility 3, 4
• Metoclopramide long-term: Risk of irreversible tardive dyskinesia, especially in elderly; European Medicines Agency recommends against long-term use 1
• Sodium-based laxatives: Can cause sodium and water retention 1

Special Situations

If patient is on opioids (common in paraplegics for neuropathic pain):

• Consider methylnaltrexone 0.15mg/kg subcutaneously every other day (peripherally-acting mu-opioid receptor antagonist) 2
• This blocks opioid effects on GI tract while preserving analgesia
• Contraindicated in mechanical bowel obstruction

Goal of therapy: Achieve one non-forced bowel movement every 1-2 days 3, 2. This prevents both constipation and overflow incontinence, which are the two extremes of neurogenic bowel dysfunction.

Assessment Before Escalating Therapy

Before adding medications, always rule out:

• Fecal impaction (may present paradoxically as diarrhea from overflow)
• Mechanical obstruction (physical exam, abdominal X-ray)
• Metabolic causes: hypercalcemia, hypokalemia, hypothyroidism 2

Quality of Life Impact

The evidence consistently shows that transanal irrigation (when combined with pharmacological management) provides superior outcomes compared to medications alone in spinal cord injury patients, improving constipation scores, reducing bowel care time by 27 minutes, and increasing patient satisfaction 4. However, this requires physical capability and patient acceptance, so medications remain the cornerstone of initial management.

The stepwise approach allows titration based on individual response while minimizing side effects. Most paraplegic patients will achieve adequate bowel management with the first or second-line pharmacological interventions when combined with adequate hydration and a consistent bowel program schedule 5, 6, 7.